Related Experiment Video
Updated: Feb 23, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
The treatment of paraprotein-related kidney disease
Colin A Hutchison1, Fei Xiong, Peter Mollee
1aDepartment of Medicine, Hawke's Bay District Health Board, Hastings, New Zealand bDepartment of Medicine, University of Queensland, Brisbane, Queensland, Australia cDepartment of Renal Medicine, Auckland Hospital, Auckland, New Zealand dHaematology Department, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Purpose Of Review:
Myeloma kidney and amyloid light-chain (AL) amyloidosis remain the principal kidney complications of paraproteins. In this review, we update readers to many of the recent advances which have occurred in the care and outcomes for patients with these presentations.
Recent Findings:
Myeloma kidney has historically caused a severe acute kidney injury with very poor outcomes. The combination of new diagnostic techniques, enabling a rapid diagnosis and novel chemotherapy agents has transformed these poor outcomes for the better. Two multicentre randomized controlled trials have recently evaluated if the removal of free light chains by high cut-off haemodialysis improves renal outcomes beyond effective chemotherapy alone. Although we await the full articles of these studies to be published, abstracts suggested the studies will have contradictory primary results. In the field of AL amyloidosis, there are now novel criteria for the risk stratification of kidney outcomes which can be used in combination with markers of early kidney response to provide clinicians with powerful tools to guide patient discussions.
Summary:
Across both AL amyloidosis and myeloma kidney patient outcomes continue to improve. Principally this improvement has been driven by the continuing development of novel chemotherapy agents in this field.
More Related Videos
07:11Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
Published on: July 19, 2018
12:22The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury V: Interprofessional Care
Kidney Transplant III: Nursing Management
Kidney Transplant II: Surgical Procedure
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management